Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout

NCT00663169 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Gouty

Interventions

BIOLOGICAL: canakinumab
DRUG: dexamethasone
OTHER: placebo matching canakinumab
OTHER: placebo matching dexamethasone

Sponsor

Novartis